Brainomix, an Oxford-born company pioneering AI-powered imaging tools in stroke and lung fibrosis, has clinched an $18 ...

After a rough patch, it seems the biotech industry may be staging a comeback. Several biotech firms have gone public this ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allurion Technologies (ALUR – Research Report), ...

Guggenheim raised the firm’s price target on InflaRx (IFRX) to $10 from $7 and keeps a Buy rating on the shares. All programs remain on track ...

CollPlant Biotechnologies , or "CollPlant", a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue ...

VolitionRx Limited ("Volition" or the "Company"), a multi-national epigenetics company, announces today that it has entered into definitive agreements for the purchase and sale of (i) 2,363,636 shares ...